<DOC>
	<DOCNO>NCT00243295</DOCNO>
	<brief_summary>To assess feasibility use rhBMP-2/CPM OWO surgical model pharmacodynamic study , assessment follow parameter : - Injecting desired volume rhBMP-2/CPM within defect - Conducting longitudinal radiographic absorptiometry tibial defect presence rhBMP-2/CPM .</brief_summary>
	<brief_title>Study Evaluating rhMBP-2/CPM Open Wedge Osteotomies</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Male female subject 45 70 year age Within 96 hour prior dose , subject underwent successful open wedge tibial osteotomy correct medial compartment OA knee . Female subject childbearing potential must negative pregnancy test ( hospital acceptable test ) , upon hospitalization OWO agree use medically approve contraception duration study . Other inclusion applies . Subjects preexist condition knee tibia would confound interpretation result . Subjects surgery opposite knee plan 6 month followup . Subjects history malignancy radiotherapy chemotherapy malignancy within past 5 year , except subject history basal skin carcinoma . Other exclusion applies .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>osteoarthritis</keyword>
	<keyword>deformity knee</keyword>
</DOC>